Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.93 USD | +1.81% | -3.20% | -23.54% |
Evolution of the average Target Price on Vistagen Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Vistagen Therapeutics, Inc.
Jefferies & Co. | |
Stifel Nicolaus | |
Maxim | |
William Blair & Co. | |
Baird |
EPS Revisions
- Stock Market
- Equities
- VTGN Stock
- Consensus Vistagen Therapeutics, Inc.